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Abstract
Background: Trials have brought diverse results of bone marrow stem cell treatment in necrotic myocardium. This
substudy from the Autologous Stem Cell Transplantation in Acute Myocardial Infarction trial (ASTAMI) explored
global and regional myocardial function after intracoronary injection of autologous mononuclear bone marrow
cells (mBMC) in acute anterior wall myocardial infarction treated with percutaneous coronary intervention.
Methods: Cardiovascular magnetic resonance (CMR) tagging was performed 2-3 weeks and 6 months after
revascularization in 15 patients treated with intracoronary stem cell injection (mBMC group) and in 13 controls
without sham injection. Global and regional left ventricular (LV) strain and LV twist were correlated to cine CMR
and late gadolinium enhancement (LGE).
Results: In the control group myocardial function as measured by strain improved for the global LV (6 months:
-13.1 ± 2.4 versus 2-3 weeks: -11.9 ± 3.4%, p = 0.014) and for the infarct zone (-11.8 ± 3.0 versus -9.3 ± 4.1%, p =
0.001), and significantly more than in the mBMC group (inter-group p = 0.027 for global strain, respectively p =
0.009 for infarct zone strain). LV infarct mass decreased (35.7 ± 20.4 versus 45.7 ± 29.5 g, p = 0.024), also
significantly more pronounced than the mBMC group (inter-group p = 0.034). LV twist was initially low and
remained unchanged irrespective of therapy.
Conclusions: LGE and strain findings quite similarly demonstrate subtle differences between the mBMC and
control groups. Intracoronary injection of autologous mBMC did not strengthen regional or global myocardial
function in this substudy.
Trial registration: ClinicalTrials.gov: NCT00199823
Background
Different studies have brought diverse results on the
effects of cell therapy in acute myocardial infarction.
Effect measures have included clinical parameters and
measurements of global left ventricular (LV) function
obtained through a spectrum of methods [1-6]. Some
groups have explored regional left ventricular function
as evaluated by wall motion or wall thickening assessed
from cardiovascular magnetic resonance (CMR) or myo-
cardial remodeling assessed from strain echocardiogra-
phy [4,7-10]. Treatment for large myocardial infarctions
is considered more challenging due to risk for LV dilata-
tion and progressive ejection fraction (EF) reduction,
and in three of the studies subgroup analyses have indi-
cated a more substantial beneficial effect from stem cell
therapy in large infarctions or in hearts with low LV EF
[8,9,11]. Myocardial strain calculated from CMR tagging
is currently regarded as the non-invasive gold standard
for assessment of regional function. However, limited
availability and analysis effort seem to reduce the overall
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any medium, provided the original work is properly cited.use of the method [12,13]. In this substudy of the Autolo-
gous Stem Cell Transplantation in Acute Myocardial
Infarction trial (ASTAMI) [2], we calculated LV circum-
ferential strain and twist from short axis grid CMR tag-
ging obtained on 28 patients first at 2-3 weeks and then
subsequently 6 months after the infarction. We examined
whether intracoronary injection of autologous mononuc-
lear bone marrow cells (mBMC) influenced regional
myocardial function or LV twist. In addition, we aimed
to explore the potentials for tagging analysis to detect
more subtle changes in myocardial function undetectable
by other examination techniques in routine use.
Methods
Study group
Methods and techniques used in the ASTAMI trial have
been reported in detail previously [2]. Briefly, 100 patients
with acute left anterior descending artery (LAD) myocar-
dial infarction were randomized to either intracoronary
injection of autologous mBMC (mBMC group) or control
with no sham injection after successful revascularization.
mBMC injection was performed 4-8 days (mean 6 days)
after percutaneous coronary intervention (PCI). Baseline
CMR was performed after 2-3 weeks (18.8 ± 3.8 days)
after myocardial infarction and was repeated after
6 months. For this substudy, the CMR protocol included
short axis grid tagging sequences in addition to cine
images and post contrast late gadolinium enhancement
(LGE). The patients were a consecutive series of the last
28 patients included in ASTAMI who either received
mBMC per protocol (n = 15) or belonged to the control
group (n = 13). The study complies with the Declaration
of Helsinki, and the protocol was approved by the regional
committee for research ethics. All patients gave written,
informed consent.
Cardiac Magnetic Resonance
Cine images, tagging sequences and late enhancement
images were acquired in the same image session with
1.5 tesla units (Magnetom Vision Plus or Magnetom
Sonata, Siemens, Erlangen, Germany) with a phased
array body coil.
Two cine long axis projections of the left ventricle were
acquired with either a breath-hold segmented spoiled
gradient echo sequence, fast low angle shot (FLASH) or a
breath-hold segmented balanced gradient echo sequence,
fast imaging with steady-state free precession (trueFISP).
Each patient had either paired FLASH or paired trueFISP
examinations. Temporal resolution was 50 ms or less and
slice thickness was 6 mm.
Tagged CMR of the left ventricle was obtained with a
FLASH sequence. Three short axis levels were standar-
dized with the basal level just apical to the mitral ring at
end-systole, the mid-ventricular level on the mid-point
of the left ventricular long axis, and apical level just
basal to the level of luminal closure at end-systole.
Orthogonal tags in a grid pattern were parallel or per-
pendicular to the 2-chamber long axis plane with dis-
tance between tags of 8 mm. Temporal resolution was
less than 50 ms and slice thickness 6 or 8 mm.
Late enhancement images were obtained 10 - 20 min-
utes after intravenous injection of 0.2 mmol/kg gado-
pentetate dimeglumine (Magnevist, Schering, Berlin,
Germany) in two long axis projections corresponding to
the cine images and multiple short axis projections cov-
ering the LV with a breath-hold inversion recovery
turbo gradient echo sequence. The inversion time was
chosen to null the signal of the normal myocardium.
Slice thickness was 7 or 8 mm and increment between
slices was 10 mm.
CMR analysis
All CMR analyses were performed blinded to treatment
allocation. End diastolic volumes (EDV), end systolic
volumes (ESV) and EF were calculated according to the
biplane area-length method from the two long axis cine
projections [14].
Tagging recordings were analyzed with Harmonic
Phase Imaging (HARP version 1.0, Diagnosoft Inc, Palo
Alto, California). For each slice, 24 mid-wall points were
semi-automatically tracked, and circumferential Lagran-
gian end systolic strain was calculated from deformation
of the line between points. Each of the 24 strain mea-
surements were manually assigned to the 16 segment
model [15], and mean strainw a so b t a i n e df o ra l ls e g -
ments, selected LV regions and the global LV. By con-
vention negative strain indicates myocardial shortening.
Typical segmental tagging analysis of an apical slice is
illustrated in Figure 1.
Segments were excluded for further analysis if more
than half of the segment’s strain curves had been
excluded due to noise. The LV regions were excluded
for further analysis if more than half of the segments in
the region had been excluded. Global mean strain values
were excluded if more than 50% of the segments had
been excluded or if either the basal, mid-ventricular or
apical slices suffered from missing segmental data.
LV rotation data were obtained from the mid-wall
tracking also made for strain analysis in the basal and
apical slices, values given in degrees. LV twist was calcu-
lated as basal rotation subtracted from apical rotation.
Strain and twist inter- and intra-observer reproducibility
was assessed through repeated analyses of 10 randomly
chosen tagging examinations.
Late enhancement short axis slices were manually
assigned to basal, mid or apical left ventricular slices
and divided into sectors to fit the 16 segment model
[15]. Myocardial borders and the enhancing areas were
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Absolute and relative myocardial infarct volumes were
obtained for each segment. Myocardial and infarct
masses were converted from volume by multiplying by
1.05 g/ml [19].
LGE and strain data were analyzed globally and in
corresponding LV regions, based on baseline LGE find-
ings. All infarct segments in each patient were sum-
marized, denoted infarct zone. All segments without
late enhancement were denoted remote segments. Seg-
ments with more than 75% infarct were studied selec-
tively, denoted transmural infarct zone, corresponding
to the transmurally infarcted segments studied by
Herbots et al. [8].
Statistics
Categorical variables were analyzed with the chi-square
test. Continuous data are presented as mean ± standard
deviation, and in the gross material all variables for
baseline and end-point analyses approximated a normal
distribution. For comparisons between groups at base-
line two-sample t-tests were performed. Intra-group
changes were evaluated by paired sample t-tests. Devel-
opment between 2-3 weeks and 6 months was assessed
by analysis of covariance, with the baseline values used
as a covariate. Corresponding analyses were performed
on patients with lower than median EF at baseline
CMR. Owing to the relatively low number of patients
inter-group comparisons were performed with the
segmental strain
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Figure 1 Baseline apical tagging analysis in a 49 year old male patient in the mBMC group. Upper part: The curves represent strain in the
apical segments, analyzed with HARP software from a short axis CMR tagging sequence. The vertical box represents the end systolic frame (F6).
There is almost normal function in the lateral wall, dysfunction in the inferior wall, while septum and the anterior wall are almost akinetic with
possible post-systolic contraction. Note increasing noise during diastolic frames, due to T1 relaxation of the tagged myocardium. Lower part: Left:
Short axis apical LGE image with hyperintensity in the anterior wall, septum and part of the inferior wall. Mid and right: Short axis apical end
diastolic (mid) and end systolic (right) tagging images with application of the semi-automatically traced lines from HARP software.
Circumferential mid-wall end systolic strain was calculated from deformation of the orange mid-wall line.
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change was evaluated with the Wilcoxon signed ranks
test. For tagging reproducibility two-way mixed absolute
agreement intraclass correlation analyses of global and
regional strain and twist were performed. The intraclass
correlation coefficients (ICC) are presented with 95%
confidence interval. SPSS software version 16.0 was
used. Tests were two-sided, and p-values < 0.05 were
considered statistically significant.
Results
Patient characteristics and LV measurements
Among all patients, the mean age was 58.6 ± 9.1 years,
mean time from the onset of symptoms to PCI was 234 ±
104 minutes, and the mean value for maximum creatine
kinase MB was 361 ± 136 μg per liter. The characteristics
of the patients at admission did not differ significantly
between the two groups (Table 1).
The results of volumetric, LGE, strain and twist ana-
lyses for all patients are summarized in Table 2, and
selected results for the group of patients with baseline
EF lower than median (51.9%) are summarized in Table
3. At baseline, there were no significant differences
between the groups for EF, ESV, EDV, LV mass, infarct
size, LV strain or LV twist, and there were no significant
differences in myocardial mass, infarct mass, infarct per-
cent or strain in the LV regions examined.
EDV and ESV did not change over time, but there was
a trend towards increased EF from the baseline exami-
nation to 6 months, irrespective of treatment allocation.
In the subgroup of patients with low baseline EF, EF
increased significantly (43.7 ± 7.2 to 51.9 ± 8.8%, p =
0.042) and ESV decreased significantly (114.8 ± 38.1 to
95.2 ± 43.6 ml, p = 0.043) in the control group but did
not change in the mBMC group.
Late gadolinium enhancement
Average segmental LGE at baseline is illustrated in
Figure 2a. All 448 segments in all 28 patients were
included for LGE analysis at both time points. The indivi-
dual LV infarct percent at baseline ranged from 2.2% to
50.1%. Ten patients had small (< 18%), 9 had intermedi-
ate (18-30%) and 9 had large infarcts (> 30%) [20]. A
total of 271 segments were judged as partially or comple-
tely infarcted at baseline, respectively 266 at 6 months.
The infarcts affected the basal segments of LV in 15
patients only; 14 of these had large and medium-sized
infarcts. In all but 1 patient the infarct involved at least 1
segment outside the presumed LAD supplying territory
[15]. In the mid-ventricular part of LV, there was LGE in
the inferior septum in 26 patients and in the anterior lat-
eral wall in 23 patients. In the apical part the inferior and
lateral segments were infarcted in 27 and 24 patients,
respectively. LV infarct mass and infarct percent
decreased significantly from baseline to 6 months in the
control group only, and there was significant difference
between the mBMC and control groups. Regionally,
infarct percent decreased significantly in the infarct zone
of the control group, and in the transmural infarct zone
of both groups. Infarct mass of the infarct zone decreased
significantly more in the control group than in the
mBMC group. In the group of patients with low baseline
EF, infarct percent in the infarct zone decreased more in
the controls than in the mBMC patients.
LV function
Average segmental strain at baseline is illustrated in
Figure 2b. Forty-six segments were excluded for strain
analysis at baseline, and 35 segments were excluded at
6 months. LV strain was analyzed in 26 patients.
Regionally, infarct zone strain and strain of remote
Table 1 Patient characteristics at admission
mBMC (n = 15) Controls (n = 13) p-value
Age - years 58.5 ± 8.9 58.7 ± 9.7 0.965
Female sex - no 3 3 0.843
Body mass index 25.7 ± 2.6 27.1 ± 3.2 0.240
Current smokers - no 5 3 0.836
Hypertension - no 2 3 0.502
Diabetes mellitus - no 1 1 0.916
Previous angina - no 2 4 0.262
Blood pressure - mm Hg
systolic 133 ± 21 125 ± 18 0.320
diastolic 79 ± 12 78 ± 13 0.807
Heart rate - beats/min 71 ± 12 80 ± 14 0.090
Time from symptom onset to PCI - min 239 ± 100 228 ± 112 0.780
Maximum creatine kinase MB - μg/l 382 ± 130 334 ± 143 0.376
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had 1 or more segments with more than 75% infarct,
and all were included for transmural infarct zone strain
analyses. The ICC of agreement for inter-observer judg-
ments was 0.97 (0.87-0.99) for global strain, 0.96 (0.83-
0.99) for infarct zone strain and 0.95 (0.65-0.99) for
transmural infarct zone strain. Corresponding ICC of
agreement for intra-observer observations was 0.99
(0.95-1.00), 0.98 (0.81-0.99) and 0.96 (0.82-0.99)
respectively. For individual segments agreement was
lower with an ICC of 0.81 (0.75-0.86) for intra-observer
and 0.87 (0.83-0.91) for inter-observer judgments.
LV function as measured by global strain improved sig-
nificantly from baseline to 6 months in the control group
(from -11.9 ± 3.4 to -13.1 ± 2.4%, p = 0.014), but remained
unchanged in the mBMC group. In the control group,
regional myocardial function improved significantly in the
infarct zone (from -9.3 ± 4.1 to -11.8 ± 3.0%, p = 0.001),
Table 2 Global and regional results; all patients (n = 28)
Baseline 6 months
mBMC controls p-value 1 mBMC controls p-value 2
Left ventricle
N=2 8
EDV - ml 175.1 ± 48.7 176.8 ± 52.8 0.932 174.9 ± 60.0 174.3 ± 62.3 0.828
ESV - ml 91.2 ± 35.2 84.9 ± 41.0 0.668 87.6 ± 44.9 78.0 ± 42.3 0.674
EF - % 49.3 ± 9.5 54.1 ± 11.3 0.233 52.4 ± 11.9 57.9 ± 10.1 0.610
LV mass - g 168.6 ± 28.3 171.5 ± 42.1 0.831 162.4 ± 30.8 160.4 ± 41.1* 0.379
infarct mass - g 38.6 ± 23.3 45.7 ± 29.5 0.484 37.6 ± 20.5 35.7 ± 20.4* 0.034
infarct percent - % 22.1 ± 12.4 26.4 ± 14.8 0.410 22.2 ± 10.8 22.0 ± 11.0* 0.026
global strain - % -11.1 ± 2.4 -11.9 ± 3.4 0.512 -11.1 ± 2.6 -13.1 ± 2.4* 0.027
twist - ° 11.3 ± 3.6 12.8 ± 5.4 0.365 12.6 ± 4.3 11.8 ± 3.7 0.411
Infarct zone
N=2 7
mass - g 103.0 ± 39.6 103.9 ± 37.6 0.955 100.3 ± 39.9 96.2 ± 34.5* 0.217
infarct mass - g 38.6 ± 23.3 45.7 ± 29.5 0.484 37.6 ± 20.5 35.7 ± 20.4* 0.034
infarct percent - % 34.4 ± 13.6 41.5 ± 17.7 0.242 34.3 ± 12.6 35.0 ± 11.6* 0.084
strain - % -9.7 ± 3.4 -9.3 ± 4.1 0.770 -10.2 ± 3.3 -11.8 ± 3.0* 0.009
Transmural infarct zone
N=1 3
mass - g 32.3 ± 22.6 35.0 ± 26.2 0.855 33.7 ± 21.4 33.6 ± 24.0 0.519
infarct mass - g 29.0 ± 23.0 32.5 ± 25.2 0.804 26.6 ± 17.7 26.1 ± 19.5 0.468
infarct percent - % 86.8 ± 7.4 90.3 ± 6.1 0.377 77.6 ± 4.3* 76.6 ± 11.4* 0.401
strain - % -2.0 ± 1.5 -6.6 ± 5.6 0.107 -2.4 ± 1.4 -8.6 ± 4.9 0.108
Remote segments
N=2 7
mass - g 64.4 ± 22.1 66.5 ± 24.3 0.816 61.1 ± 22.8 63.2 ± 24.0 0.965
strain - % -14.4 ± 2.4 -14.9 ± 2.3 0.560 -14.3 ± 3.3 -15.6 ± 2.3 0.195
p-value 1 refers to between group differences at baseline (two sample t-test). p-value 2 refers to between group differences in changes from baseline (analysis of
covariance). *p < 0.05 for intra-group changes from baseline, evaluated by paired sample t-test.
Table 3 Selected results; patients with baseline EF < median (51.9%)
Baseline 6 months
mBMC controls p-value 1 mBMC controls p-value 2
Left ventricle
N=1 4
EDV - ml 183.2 ± 46.1 202.9 ± 49.3 0.641 194.6 ± 64.4 191.6 ± 55.6 0.162
ESV - ml 105.1 ± 33.1 114.8 ± 38.1 0.640 107.7 ± 43.4 95.2 ± 43.6* 0.028
EF - % 43.3 ± 6.4 43.7 ± 7.2 0.947 45.8 ± 7.1 51.9 ± 8.8* 0.386
infarct percent - % 28.8 ± 10.7 33.5 ± 12.1 0.505 27.2 ± 8.8 28.7 ± 12.1* 0.071
global strain - % -10.0 ± 2.4 -11.3 ± 2.9 0.536 -11.4 ± 2.8 -13.0 ± 2.8 0.189
Infarct zone
N=1 4
infarct percent - % 41.0 ± 12.4 46.6 ± 11.9 0.463 37.9 ± 10.1* 38.8 ± 11.4* 0.053
strain - % -8.7 ± 2.9 -8.9 ± 2.7 0.738 -9.9 ± 3.1 -11.7 ± 2.4* 0.205
Transmural infarct zone
N=9
infarct percent - % 86.8 ± 7.4 90.5 ± 7.7 0.462 77.6 ± 4.3* 79.2 ± 12.7 0.327
strain - % -2.0 ± 1.5 -4.6 ± 4.9 0.221 -2.4 ± 1.4 -8.6 ± 5.9 0.027
p-value 1 refers to between group differences at baseline (Mann-Whitney). p-value 2 refers to between group differences in changes from baseline (Mann-
Whitney). *p < 0.05 for intra-group differences from baseline, evaluated by Wilcoxon signed rank test.
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ments. Regional myocardial function remained unchanged
in the mBMC patients. In the group of patients with low
baseline EF, strain improvement was significantly more
pronounced for the controls in the transmural infarct
zone only. LV twist was analyzed in all 28 patients. Twist
was low at baseline for both groups, and did not change
significantly over time in either of the groups. The ICC of
agreement for inter-observer judgments was 0.92 (0.74-
0.98) and for intra-observer observations 0.96 (0.85-0.99).
The changes of LV strain in the control group corre-
lated significantly with LV infarction mass at baseline
and change of LV infarction mass (Table 4).
Discussion
The ASTAMI study, which included 100 patients, was
originally designed with a power of 80% to reveal a
potential difference of 5% points of LV EF development
between the mBMC and the control groups as measured
by single-photon-emission computed tomography. No
difference was found for global functional development
or for clinical parameters [2,21]. For LV EF inter-
observer variability was assessed with ICC of 0.85 (0.67-
0.93) for FLASH cines and ICC of 0.98 (0.96-0.99) for
trueFisp cines [2] (Supplementary Appendix). In this
substudy, only 28 patients were included, resulting in
reduced power. Unlike previous reports, myocardial wall
function developed beneficially for the control group as
compared with the mBMC group. Strain improvement
was 2.5 ± 2.0% points in the infarct zone and 1.6 ± 1.8%
points globally. Infarct mass as shown by LGE developed
similarly to strain, with a more pronounced infarct mass
reduction for the controls than for the mBMC group.
Both groups had a parallel, but statistically non-
significant trend towards LV EF improvement. The
results from this study illuminate the potentials for
detailed regional myocardial examination to detect subtle
differences of myocardial function not always detected by
other examination techniques routinely used.
Care must be taken drawing conclusions from the
results regarding development of myocardial function
and LGE in this study. Recently, Beitnes et al. published
results from the long-term follow-up of the ASTAMI
trial including global and regional LAD strain analyses
performed with longitudinal two-dimensional speckle-
tracking echocardiography (2D STE) [10]. They reported
a significant improvement of regional and global peak
systolic strain from baseline to 6 months, which was
maintained at three years post-infarction. However,
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Figure 2 Bull’s eye plots over baseline LGE and strain in the 16 LV segments model. 2 a: Average infarct involvement (percent) in each
segment (n = 448). 2 b: Average strain (percent) in each segment (n = 402). Negative strain values indicate myocardial shortening, and a strain
value with amplitude higher than -14% is considered normal.
Table 4 Correlation between strain development and
infarct mass in controls
Beta (standardized) R p-value
LV infarct mass at baseline -0.663 0.663 0.019
Change of infarct mass 0.665 0.665 0.018
Dependent variable: change of LV strain
Linear regression analysis for correlation between change of LV strain
(dependent) and baseline LV infarct mass and change of LV infarct mass in
controls (n = 12).
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regarding change in myocardial systolic or diastolic
function. The present substudy introduces some metho-
dological refinement to this study. Circumferential strain
was calculated from short axis CMR tagging versus
longitudinal strain calculation from long axis 2D STE.
For the regional CMR tagging analysis the infarct zone
was directly defined by findings from baseline LGE,
achieved during the same image session. Inter- and
intra-observer strain reproducibility was excellent for
global and regional strain analyses, even though repro-
ducibility decreased when strain was studied on the
individual segmental level. For the echo examination
there was no opportunity to directly delineate the myo-
cardial infarct area, and the region studied was the pre-
defined LAD territory. Additionally, strain calculations
were made at different time points. Baseline of the echo
study was 4.5 ± 1.1 days after the myocardial infarction,
b e f o r et h eb o n em a r r o wa s p iration and intracoronary
mBMC injection of the mBMC group, whereas the base-
line CMR examination was performed at 18.8 ±
3.8 days. This fact is also relevant for the comparison of
t h eg l o b a lL Vv o l u m e t r i ca n a l y s e s .E v e nt h o u g ht h e
groups did not develop significantly differently, the
CMR examinations in the main ASTAMI study revealed
a larger increase of LV EF (1.2% vs 4.3%, p = 0.054),
and a larger decrease of infarct size (-2.3 vs -5.9 ml, p =
0.11) in the control group than the mBMC group [2].
There were no between-group differences in baseline
infarct mass in the larger, main ASTAMI study.
Although not significant, the baseline infarct mass in
the substudy was slightly, but not significantly higher in
the control group than in the mBMC group. Strain
values in the ischemic heart are closely related to LGE
[22-24], and strain improves over time after acute myo-
cardial infarction [25]. In the present study, there was a
significant correlation between improvement of strain
and reduction of infarct size in the control group
(Table 4). Part of the differences between the study groups
may have been caused by the small study group bias.
In the main ASTAMI study, 72% of the patients who
received intracoronary cell injections reported mild
chest pain during the procedure and 77% had transient
ischemic ST deviation during balloon inflation. No
patient had reinfarction related to the procedure [2].
Beitnes et al. recently reported no adverse effects
observed after three years in the same population [21].
Thus, there is no indication that the intracoronary bal-
loon inflation procedure has influenced the clinical
results of the mBMC group. The present study was not
designed to reveal any subtle immediate beneficial or
unfavorable changes in the myocardium after intracor-
onary injection of mBMC. One might speculate, how-
ever, that recurrent balloon inflations might negatively
influence myocardial function in the treatment perfusion
area, as indicated in our results.
Regional wall function has been investigated by differ-
ent means in other stem cell trials. In the Repair-AMI
trial regional function improved more in infarcted areas
in the stem cell group judged by the centerline chord
method at 4 months [6]. In a recent CMR substudy by
Dill et al., infarct area wall thickening was assessed by
cine CMR examination, and the results indicated more
pronounced increase of wall thickening in the stem cell
group after 12 months in the group of patients with
initial EF lower than median EF (48.9%) [9]. In the
BOOST trial, wall thickening and wall motion in
infarcted areas were studied by short axis cine CMR.
There was no significant treatment effect from stem cell
i n j e c t i o no ng l o b a lL V E Fo ro nt h er e g i o n a lf u n c t i o n
parameters studied at 18 months or 5 years follow up
[7,26]. In the trial from Leuven wall thickening was
assessed by short axis cine CMR in transmurally and
non-transmurally infarcted segments. The change in sys-
tolic function did not differ at 4 months between the
stem cell group and the placebo group [5]. However,
there was a beneficial stem cell treatment effect on
strain as measured by tissue Doppler imaging for seg-
ments with initial LGE involvement of more than 75%
[8]. The results from our substudy do not support any
potential beneficial effect from intracoronary injection of
mBMC after reperfused myocardial infarction. This also
applies to the patients with larger transmural myocardial
infarcts and those with low EF.
End systolic LV twist is the difference in the systolic
clockwise rotational movement of the basal region from
the counter-clockwise rotational movement of the apical
region as seen from the apex. The rotation is part of the
complex wringing movement of the left ventricle during
systole [27,28]. Baseline end systolic LV twist values in
our study were 11.3 ± 3.6°and 12.8 ± 5.4°in the mBMC
group and controls, respectively. Despite lack of healthy
controls for comparison, we regard these values to be
clearly lower than the normal values as measured by
speckle-tracking echocardiography [29,30]. Reproducibil-
ity was excellent, with ICC of 0.92 and 0.96 for inter-
and intra-observer variability, respectively. Several
authors have found reduced twist in acute or chronic
myocardial ischemia compared with twist in healthy
individuals, and twist reduction is correlated to the
extent of LV EF reduction [29,31,32]. Twist and the
more simplified apical torsion have been suggested as
reliable and sensitive tools to detect LV dysfunction. In
a patient group of acute LAD myocardial infarction,
Han et al. found a positive correlation between LV EF
and twist, and in addition twist significantly improved
one month after revascularization, parallel to a mean EF
increase from 38.8% to 49.7% [33]. In the present study
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ferentiating smaller from larger infarctions, are needed
to evaluate potentials and clinical significance for twist
development after acute myocardial infarction.
According to the standardized scheme for myocardial
territory assignment the LAD artery supplies the ante-
rior wall and the anterior part of the septum, as well as
the apical septum and the apical cap [15]. Ortiz-Pérez et
al. have suggested a modification to this scheme, adding
the mid anterolateral segment and the apical lateral and
inferior segments to the LAD territory [34]. Individual
variation will add complexity to these schemes in any
patient studies. In the present study, only patients with
their first ST-elevation anterior wall infarction were
included. Small, medium-sized and large infarcts were
quite evenly represented. The relative lack of basal slice
LGE in the small infarcts probably was a consequence
of the site for LAD occlusion. In the mid-ventricular
slices LGE of the anterior lateral wall and the inferior
part of the septum was of similar magnitude, and quite
significant. Visually, the LGE areas of these segments
were fringes of the LGE in the neighboring LAD terri-
tory segments. In the apical slices all segments were lar-
gely affected, supporting the modification suggested by
Ortiz-Pérez et al. [34]. As illustrated in Figure 2 average
reduction of segmental strain followed a pattern similar
to the average LGE involvement, although strain values
were relatively lower in the septum.
Limitations
The time point for the baseline CMR at least two weeks
after the acute event was chosen to reduce overestima-
tion of infarct size owing to tissue edema, and
T2-weighted sequences for evaluation of edema were
therefore not part of our protocol. Obviously, more
information on LV volumes and function could have
been available with an additional CMR examination
before or immediately after intracoronary cell injection.
Thus, we may have missed early and short term changes
after the injection, and thereby possible differences
between the groups, either related to stem cell effect, or
even to the intracoronary balloon inflation procedure
itself. This fact also is relevant for the direct comparison
between echo and CMR results. However, the time
point for baseline CMR examination was suitable for the
investigation of myocardial remodeling after the acute
phase. Serial CMR studies underscore the advantages of
examining LGE after the first 7 days of resorption
of necrotic myocardium and hemorrhage, reduction of
myocardial edema and possibly rescue of myocardium at
risk. A better correlation was found between later func-
tional parameters and LGE after one week compared
with LGE immediately after the infarction and reperfu-
sion [35-37].
Short duration of follow-up and a relatively small
number of patients, even reduced by exclusions from
tagging noise; make the present study insufficient in the
assessment of post mBMC treatment effects. LV EF was
examined with the area-length method, possibly adding
variability compared with multiple short-axis cines. Dif-
ferences in development may have been masked. The
selection of patients did not completely concur with the
main ASTAMI study, with a non-significant, numerically
slightly higher initial infarct mass in the control group
than the mBMC group.
Conclusions
The results from the present study do not support the
hypothesis that intracoronary mBMC injection after
reperfused anterior wall infarction reduces infarct size
or improves myocardial function. Findings from regional
LGE and strain analyses quite similarly demonstrate
subtle differences between the mBMC and control
groups with a slightly more favorable development in
the controls. The potential role for LV twist as assessed
by CMR tagging has to be evaluated in further studies.
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